½ÃÀ庸°í¼­
»óǰÄÚµå
1304271

µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå : ¿ëµµº°, Á¦Ç° À¯Çüº°, ÆÇ¸Å ä³Îº°(BtoB, BtoC), Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2023-2030³â)

Digital Therapeutics Market, By Application, By Product Type, By Sales Channel ((Business-to-Business and Business-to-Consumer, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐ Ä¡·áÁ¦(Digital Therapeutics, DTx)´Â ÀÇ·áÀû Àå¾Ö³ª Áúº´À» ¿¹¹æ, °ü¸®, Ä¡·áÇϱâ À§ÇÑ ¼ÒÇÁÆ®¿þ¾î¿¡ ÀÇÇÑ Áõ°Å ±â¹Ý Ä¡·á °³ÀÔÀÔ´Ï´Ù. µðÁöÅÐ Ä¡·áÁ¦´Â µðÁöÅÐ ÇコÄɾîÀÇ ÇÑ ºÎºÐÀ¸·Î, ÀÓ»óÀûÀ¸·Î Æò°¡µÈ Áõ°Å ±â¹ÝÀÇ Áúº´ °ü¸®¿ë ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇØ ȯÀÚ¿¡°Ô Á÷Á¢ÀûÀ¸·Î Ä¡·áÀû °³ÀÔÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¸¸¼º ÁúȯÀÇ ºÎ´ã Áõ°¡, Äڷγª19(ÆÒµ¥¹Í) ¹ß»ý, ȯÀÚ Áß½ÉÀÇ ÇコÄÉ¾î ¾Û Ã¤Åà Áõ°¡, µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼Ç ¹× ±â¼ú äÅà Áõ°¡, Á¤ºÎÀÇ ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ¼¼°è µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, 2022³â 2¿ù ´ÙÀ̳ª¹ÌÄɾî Çコ(DynamiCare Health Inc.)´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ÀӽŠ¹× Ãâ»ê°ú °ü·ÃµÈ ´ã¹è »ç¿ë Àå¾Ö¸¦ Ä¡·áÇϴ ó¹æÀü Àü¿ë µðÁöÅÐ Ä¡·áÁ¦ DCH-001¿¡ ´ëÇÑ Çõ½ÅÀû ÀåÄ¡ ÁöÁ¤À» ¹Þ¾Ò´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

¶ÇÇÑ, ¾Æ¸Þ¸®¼Ò½º¹ö°ÕÀº 2022³â 7¿ù¿¡ Çõ½ÅÀûÀÎ Á¦Ç°¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ µðÁöÅÐ Ä¡·áÁ¦(DTx) Ç÷§ÆûÀ» Ãâ½ÃÇÒ °èȹÀÔ´Ï´Ù. ÀÌ Ç÷§ÆûÀ» ÅëÇØ ÀÇ»ç´Â ÀüÀÚ Ã³¹æ ¿öÅ©Ç÷ο츦 ÅëÇØ ó¹æ ¹× ºñó¹æ DTx¿¡ ½±°Ô ¾×¼¼½ºÇϰí ÁÖ¹®ÇÒ ¼ö ÀÖÀ¸¸ç µðÁöÅÐ Ä¡·áÁ¦ ¹× Áø´ÜÀÇ È¯ÀÚ ÀÌÇà ¿©ºÎ¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â ¼¼°è µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð¿Í CAGRÀ» Á¦½ÃÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×µµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µî ´ÙÀ½°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • º» Á¶»ç ´ë»óÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc.£¨Twine Health, Inc.)µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå »óȲ °³¿ä

  • º¸°í¼­ °³¿ä
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå : ¿ëµµº°, 2018³â-2030³â

  • ´ç´¢º´
  • ºñ¸¸
  • ½ÉÇ÷°üÁúȯ(CVD)
  • ÁßÃ߽Űæ°è(CNS) Áúȯ
  • È£Èí±âÁúȯ
  • ±Ý¿¬
  • À§Àå Àå¾Ö(GID)
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°, 2018-2030³â

  • ¼ÒÇÁÆ®¿þ¾î
  • µð¹ÙÀ̽º

Á¦7Àå ¼¼°èÀÇ µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå : ÆÇ¸Åä³Îº°, 2018³â-2030³â

  • B2B
  • °í¿ëÁÖ
  • ÀÇ·á Á¦°øÀÚ
  • ±âŸ
  • B2C
  • ȯÀÚ
  • °³È£ÀÚ

Á¦8Àå ¼¼°èÀÇ µðÁöÅÐ Ä¡·áÁ¦ ½ÃÀå, Áö¿ªº°, 2018³â-2030³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Happify, Inc.
  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc.(Twine Health, Inc.)

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 23.08.10

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.

Market Dynamics:

Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.

For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.

Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.

Key features of the study:

  • This report provides in-depth analysis of the global digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.

Detailed Segmentation:

  • Global Digital Therapeutics Market, By Application:
    • Diabetes
    • Obesity
    • Cardiovascular Disease (CVD)
    • Central Nervous System (CNS) Disease
    • Respiratory Disease
    • Smoking Cessation
    • Gastrointestinal Disorder (GID)
    • Others
  • Global Digital Therapeutics Market, By Product Type:
    • Software
    • Device
  • Global Digital Therapeutics Market, By Sales Channel:
    • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
    • Business-to-Consumer (B2C)
    • Patient
    • Caregiver
  • Global Digital Therapeutics Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Happify, Inc.
    • 2Morrow, Inc.
    • Akili Interactive Labs, Inc.
    • Click Therapeutics, Inc.
    • Fitbit, Inc. (Twine Health, Inc.)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sales Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of chronic diseases around the world
    • Concerns about patient data privacy
    • Increasing adoption of digital therapeutics (DTx)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Digital Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Digital Therapeutics Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Obesity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cardiovascular Disease (CVD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Central Nervous System (CNS) Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Smoking Cessation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Gastrointestinal Disorder (GID)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Digital Therapeutics Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Device
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Digital Therapeutics Market, By Sales Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Business-to-Business (B2B)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Employer
  • Healthcare Provider
  • Others
  • Business-to-Consumer (B2C)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Patient
  • Caregiver

8. Global Digital Therapeutics Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)

9. Competitive Landscape

  • Happify, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 2Morrow, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akili Interactive Labs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Click Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fitbit, Inc. (Twine Health, Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦